Leading Belgian Teaching Hospital Selects RayStation
News Aug 10, 2016
AZ Sint-Jan Brugge – Oostende AV Hospital has selected RayStation as the sole treatment planning system for the expanding radiation therapy department at its campus in Bruges. RayStation will replace the department’s existing system and will support treatment planning for existing linacs, as well as two newly purchased machines.
RayStation will enable the department to simplify and optimize its workflows, and to take strides in adaptive planning. The agreement includes, amongst other things, the full RayStation adaptive radiation therapy package and multi-criteria optimization (MCO). Licenses have been purchased for nine concurrent users.
Geertrui Demeestere, M.D., head of the radiation therapy department at the campus in Bruges, says: “RayStation’s MCO capabilities will give us a simpler way to create optimized plans that match our clinical objectives for each individual case. The contouring tools are excellent and will save significant time while increasing accuracy.”
Bert Bakelandt, head of physics at AZ Sint-Jan – Oostende AV Hospital, Bruges, says: “Adaptive radiation therapy is an important approach for us going forward and RayStation gives us all the tools we need in a single system. Features such as rapid calculation speed and highly accurate deformable registration will enable a fast and effective adaptive therapy workflow. RaySearch has the technical expertise to tailor the installation to our requirements, including implementation of a VMware Horizon virtual desktop infrastructure solution. RayStation’s scripting tools offer the possibility to automate and optimize the treatment planning workflow.”
Johan Löf, CEO of RaySearch Laboratories, says: “We are very pleased to provide the complete treatment planning solution for AZ Sint-Jan – Oostende AV Hospital. Adaptive radiation therapy is a key focus for us, and we have designed RayStation from the outset to support this approach. We look forward to a collaboration that will bring the benefits of adaptive therapy to more patients in Bruges.”
“Lymphoma Micro-reactor” Targets Chemo-Resistant LymphomaNews
Researchers have developed a “lymphoma micro-reactor” device that exposes human lymphomas to fluid flow similar to that in the lymphatics and parts of the lymph node.READ MORE
Targeting Telomerase: A Therapeutic Strategy for Difficult-to-Treat MelanomaNews
Targeting telomerase was effective at killing NRAS-mutant melanoma cells, and the impact was further enhanced when the strategy was paired with an inhibitor of mitochondrial function, according to study results by The Wistar Institute published in Oncogene.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Structural and Molecular Biology 2018
Aug 22 - Aug 23, 2018
Asia Pacific Congress on Probiotics, Prebiotics and Nutrition
Oct 15 - Oct 16, 2018